Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML 2-23 is a potent BCR-ABL degrader operating as a PROTAC, exhibiting selective proteasome-dependent degradation of BCR-ABL within leukemia cells [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | ML 2-23 is a potent BCR-ABL degrader operating as a PROTAC, exhibiting selective proteasome-dependent degradation of BCR-ABL within leukemia cells [1]. |
In vitro | ML 2-23 (1 μM; 12 h; K562 cells) degrades BCR-ABL in a proteasome-dependent manner [1]. |
Molecular Weight | 1052.86 |
Formula | C47H53BrCl2N10O7S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML 2-23 PROTAC PROTACs inhibitor inhibit